ArticleSensors (Basel, Switzerland)2026
Biopsy Needle Integrated with Rotational Oblique Spectral Ultrasound (ROSUS) Imaging.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Biopsy procedures are essential for definitive cancer diagnosis but remain limited by the risk of accidental blood vessel puncture, which can lead to hemorrhage and procedural failure. Conventional imaging guidance often provides insufficient vascular contrast, making vessel avoidance during needle insertion challenging. A rotational oblique spectral ultrasound (ROSUS) imaging system was developed to improve vessel detection and needle guidance during biopsy procedures. The device integrates a high-frequency PMN-PT 1-3 composite transducer mounted at a 45° angle within the 18-gauge needle tip, enabling simultaneous forward- and side-looking capability. By combining synchronized rotational-axial scanning with multifrequency signal ratio (MFSR) processing, ROSUS achieved volumetric images with blood-tissue contrast ratio improvement over 1.2 dB compared to conventional B-mode signal processing while maintaining high spatial resolution of 85 µm and 424 µm in axial and lateral directions, respectively. These results demonstrate that frequency-domain spectral processing can improve vessel and tissue differentiation, offering an 18-gauge needle-integrated platform for safer and more accurate biopsy needle-based procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.